Skip Navigation



NDT Advance Access published online on September 4, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn489
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/2/497    most recent
gfn489v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cottone, S.
Right arrow Articles by Cerasola, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cottone, S.
Right arrow Articles by Cerasola, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients

Santina Cottone1, Giuseppe Mulè2, Marco Guarneri1, Alessandro Palermo2, Maria C. Lorito2, Raffaella Riccobene2, Rosalia Arsena1, Francesco Vaccaro1, Anna Vadalà1, Emilio Nardi2, Paola Cusimano2 and Giovanni Cerasola2

1 Cattedra di Nefrologia e U.O. di Malattie Renali ed Ipertensione Arteriosa 2 Cattedra di Medicina Interna, Hypertension Excellence Centre of the European Society of Hypertension, Dipartimento di Medicina Interna, Malattie Cardiovascolari e Nefrourologiche, Università di Palermo, Palermo, Italy

Correspondence and offprint requests to: Santina Cottone, Via del Vespro 129, 90127 Palermo, Italy. Tel: +39-0916554333; Fax: +39-0916554331; E-mail: sancott{at}tin.it



  Abstract

Background. Hypertension and additional non-traditional risk factors can damage the kidney directly and by promoting atherogenesis. Evidence indicates that increased oxidative stress and inflammation may mediate a large part of the effects of risk factors on the kidney. We hypothesized that in hypertensive patients (HT), oxidative stress, measured as 8-ISO-prostaglandin F2alpha (8-ISO-PGF2alpha), should raise paralleling decreasing renal function and should correlate with estimated glomerular filtration rate (eGFR).

Methods. In 626 HT with renal function ranging from stages 1 to 5 and 100 healthy controls, plasma levels of 8-ISO-PGF2alpha, high-sensitivity C-reactive protein (CRP), transforming growth factor-beta (TGF-beta) and endothelin-1 (ET-1) were measured. GFR was estimated by the Modification of Diet in Renal Disease study equation.

Results. When HT were stratified according to renal function stages, 8-ISO-PGF2alpha, CRP, TGF-beta and ET-1 increased progressively and significantly with decreasing eGFR.

The multiple regression analysis, considering eGFR as a dependent variable, showed that 8-ISO-PGF2alpha (β = –0.361, P < 0.000001), ET-1 (β = –0.197, P < 0.0001) and TGF-beta (β = –0.170, P < 0.0004) correlated independently with eGFR. All biomarkers were good predictors of eGFR <60 ml/min/1.73 m2 [receiver-operator-curve (ROC) areas]. ET-1 was shown to be the best predictor with a ROC area = 0.938; with a threshold of 4 pg/ml, 91% sensitivity and 85% specificity were observed, whereas 8-ISO had a ROC area = 0.931, and for a threshold of 329 pg/ml, sensitivity and specificity were 89%, respectively. In contrast, CRP showed the lower predictive value with a ROC area = 0.917; with a threshold of 2.52 mg/l, an 87% sensitivity and an 83% specificity were obtained.

Conclusions. Our findings are a clear-cut demonstration of a strong and negative correlation of both oxidative stress and ET-1 with renal function stages in HT. ET-1 and 8-isoprostane are predictive of eGFR.

Keywords: atherosclerosis; endothelium; inflammation; oxidative stress; renal dysfunction

Received for publication: 4. 3.08
Accepted in revised form: 6. 8.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.